Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 103.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 109.00
  • 52 Week Low: 80.50
  • Currency: UK Pounds
  • Shares Issued: 84.68m
  • Volume: 0
  • Market Cap: £87.22m
  • RiskGrade: 196

Latest ShareCast News

Diaceutics appoints new VP of marketing

By Josh White

Date: Tuesday 09 Apr 2024

(Sharecast News) - Diaceutics, a technology and solutions provider catering to the pharmaceutical and biotech industry, announced the appointment of Amie Mc Neice as vice-president of marketing on Tuesday.

Director dealings: BAT, Diaceutics execs make investments

By Josh White

Date: Tuesday 06 Jun 2023

(Sharecast News) - Among the list of director buys on Tuesday was British American Tobacco, after its chief executive picked up more than a quarter-of-a-million pounds worth of shares.

Diaceutics shares resume trading after HSBC buys SVB UK

By Josh White

Date: Monday 13 Mar 2023

(Sharecast News) - Pharmaceutical technology and service provider Diaceutics announced at mid-morning on Monday that the temporary suspension of its shares on AIM would be lifted.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 103.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 109.00
52 Week Low 80.50
Volume 0
Shares Issued 84.68m
Market Cap £87.22m
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.5% below the market average90.5% below the market average90.5% below the market average90.5% below the market average90.5% below the market average
87.1% below the sector average87.1% below the sector average87.1% below the sector average87.1% below the sector average87.1% below the sector average
Price Trend
29.24% above the market average29.24% above the market average29.24% above the market average29.24% above the market average29.24% above the market average
45.95% above the sector average45.95% above the sector average45.95% above the sector average45.95% above the sector average45.95% above the sector average
Income Not Available
Growth
5.25% above the market average5.25% above the market average5.25% above the market average5.25% above the market average5.25% above the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average

Diaceutics Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page